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Background: Although serum alkaline phosphatase (ALP) levels have been associated with hypertension, and ALP
is known as an enzyme affected by alcohol consumption, no study has been published on the associations
between ALP and the risk of hypertension in relation to drinking status.
Methods: We conducted a cross-sectional study of 2,681 participants (837 men and 1,846 women) aged 30 to 89
years undergoing a general health check-up to investigate the associations between ALP and hypertension in
relation to drinking status.
Results: Of the 2,681 participants, 1,549 (514 men and 1,035 women) were diagnosed with hypertension. A sex
difference was observed for the relationship between ALP and hypertension. While no significant association was
observed for men, the association was significantly positive for women. The multivariable adjusted odds ratio and
95% coincidence interval (CI) of hypertension per increment of 1-log ALP were 0.95 (95% CI: 0.56 to 1.59) for men
and 1.57 (95% CI: 1.07 to 2.33) for women. When this analysis was restricted to nondrinkers, a significantly elevated
risk of hypertension was observed for men and remained significant for women; that is, 3.32 (95% CI: 1.38 to 8.02)
for men and 1.68 (95% CI: 1.11 to 2.55) for women.
Conclusion: ALP is associated with hypertension for both male and female nondrinkers, but not for drinkers. For
analyses of associations between ALP and blood pressure, alcohol consumption should thus be considered a
potential confounder.
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The alkaline phosphatase (ALP) enzyme catalyzes the hy-
drolysis of inorganic pyrophosphate [1], which is an inhibi-
tor of vascular calcification [2]. While ALP is expressed in a
variety of tissues, its concentrations are notably high in
bone, liver, and kidneys [1]. One previous sex-combined
study reported that ALP was significantly associated with
hypertension [3], and another study found a weak but sta-
tistically significant association of ALP with blood pressure
[4]. On the other hand, serum ALP levels are influenced by* Correspondence: simizicyuu@yahoo.co.jp
1Department of Community Medicine, Nagasaki University Graduate School
of Biomedical Science, Nagasaki, Japan
2Department of Island and Community Medicine, Nagasaki University
Graduate School of Biomedical Science, Nagasaki, Japan
Full list of author information is available at the end of the article
© 2013 Shimizu et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the oralcohol consumption [5,6], which has been positively asso-
ciated with hypertension [7]. However, no study of the rela-
tionships between ALP and hypertension stratified by
drinking status has been published. Since a previous study
of ours established that alcohol consumption has a strong
effect on the relationship between ALP and incidence of
stroke in a general Japanese population [8], we hypothe-
sized that the associations between ALP and hypertension
might also be influenced by alcohol consumption. Since it
is known that Japanese men are characterized by a high
prevalence of current drinking and Japanese women by a
low prevalence [8-10], a Japanese population would be a
useful tool for studying this hypothesis. To examine this hy-
pothesis, we analyzed general health check-up results for
risk of hypertension for Japanese men and women.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Subjects
Written consent forms were available in Japanese to en-
sure comprehensive understanding of the study objectives,
and informed consent was signed by the participants. This
study was approved by the Ethics Committee for Use of
Humans of Nagasaki University (project registration num-
ber 0501120073).
The source population included 3,883 residents of the
western rural community of the Goto Islands (1,355 men
and 2,528 women) 30 to 89 years old, who participated in
this study between 2005 and 2010. Data for blood pressure
were missing for 11 subjects (3 men and 8 women), data
for drinking status missing for 69 subjects (23 men and 46
women), data for serum missing for 947 subjects (422
men and 525 women), and with history of cardiovascular
disease for 175 subjects (72 men and 103 women) so a
total of 1,202 subjects were excluded from this study.
There were no differences in cardiovascular disease risk
factors between participants for whom blood data were
available and those for whom they were not. The re-
maining 2,681 participants, 835 men with a mean age of
64.5 years (± 10.5 standard deviation; range 30 to 89) and
1,846 women with a mean age of 62.5 years (± 11.3 stand-
ard deviation; range 30 to 89), were enrolled in this study.
Data collection and laboratory measurements
Trained interviewers obtained information on smoking
status, drinking status, medical history, as well as use
of antihypertensive agents and medication for diabetes
mellitus. Body weight and height were measured with an
automatic body composition analyzer (BF-220; Tanita,
Tokyo, Japan) when blood samples were obtained. Sys-
tolic and diastolic blood pressures were recorded at rest.
Hypertension was defined as systolic blood pressure ≥140
mmHg and/or diastolic blood pressure ≥90 mmHg and/or
use of antihypertensive medication.
Following collection of blood samples after overnight
fasting, serum and plasma were separated and stored
at −20°C and −80°C, respectively, until assay.
Serum concentrations of triglyceride (TG), hemoglo-
bin A1c (HbA1c), aspartate transaminase (AST), γ-
glutamyltranspeptidase (γ-GTP), ALP and serum creatinine
were measured with standard laboratory procedures. The
glomerular filtration rate (GFR) was estimated by means of
an established method with three variations recently pro-
posed by a working group of the Japanese Chronic Kidney
Disease initiative [11].
According to this adapted version:
GFR ml=minute=1:73 m2
  ¼ 194
 serum creatinine enzyme methodð Þð Þ1:094
 ageð Þ0:287  0:739 for womenð ÞHbA1c(National Glycohemoglobin Standardization Pro-
gram) was calculated with the following equation recent-
ly proposed by a working group of the Japanese Diabetes
Society [12]:
HbA1c National Glycohemoglobin Standardization Programð Þ
¼ HbA1c Japanese Diabetes Societyð Þ þ 0:4%
Diabetes was defined as HbA1c(National Glycohemoglobin
Standardization Program) ≥6.5%, and/or initiation of
glucose-lowering medication or insulin therapy [13].
Statistical analysis
Since previous studies including ours have demonstrated
that Japanese men show a high prevalence of current
drinkers and Japanese women a low prevalence [8,9,14],
and since alcohol consumption has been positively as-
sociated with hypertension [7], we performed a sex-
specific analysis.
Analysis of variance or logistic regression models were
used to calculate differences in age-adjusted mean values
or prevalence of potential confounding factors in rela-
tion to ALP levels. The subjects were divided into two
groups according to smoking status (current smoker or
not), alcohol consumption, (current drinker or not), dia-
betes (no, yes) or thyroid disease (no, yes). triglycerides
(mg/dl), AST (IU/l), γ-GTP (IU/l) and GFR (ml/minute/
1.73 m2) were adjusted as continuous variables. Covari-
ance or general linear models were used to analyze dif-
ferences in sex-specific, age-adjusted mean values for
cardiovascular risk factors in relation to ALP levels, and
logistic regression models to calculate odds ratios (OR)
and 95% confidence intervals (CIs) of hypertension asso-
ciated with ALP levels. Two different approaches were
used for adjustments for confounding factors. The first
adjustment was only for age, and the second consisted
of other possible confounding factors; that is, smoking
status (never smoker, former smoker, current smoker),
alcohol consumption (nondrinker, current light to mod-
erate drinker (1 to 6 times/week) and current heavy
drinker (every day)), diabetes (no, yes), thyroid disease
(no, yes), triglycerides (mg/dl), AST (IU/l), γ-GTP (IU/l)
and GFR. Because ALP levels are strongly affected by
drinking status [5,6], we also investigated associations
between ALP and hypertension among nondrinkers.
All statistical analyses were performed with the SAS
system for Windows (version 9.3; SAS Inc., Cary, NC,
USA). All P values for statistical tests were two-tailed,
and P <0.05 was regarded as statistically significant.
Results
Of the 2,681 participants (835 men and 1,846 women),
1,549 (514 men and 1,035 men) were diagnosed with
hypertension.
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characteristics by ALP level. For both men and women,
triglycerides and γ-GTP showed significantly positive asso-
ciations with ALP levels. For men, the prevalence of
current drinkers was inversely associated with ALP levels,
and for women systolic blood pressure, diastolic blood
pressure, antihypertensive medication use and AST were
positively and significantly associated with ALP levels.Table 1 Age-adjusted mean values and proportions by alkalin
Q1 (low)
Men
Median values for serum ALP (U/l) 172
Number at risk 205
Age (years) 63.9 ± 10.0
Systolic blood pressure (mmHg) 140
Diastolic blood pressure (mmHg) 84
Antihypertensive medication use (%) 27
Thyroid disease (%) 0.0
Body mass index (kg/m2) 23.7
Current drinker (%) 62
Current smoker (%) 20
Serum triglycerides (mg/dl) 128
Diabetes (%) 8
Serum aspartate aminotransferase (AST) (IU/l) 24
Serum γ-glutamyltranspeptidase (γ-GTP ) (IU/l) 36
Serum creatinine, (mg/dl) 0.90
Glomerular filtration rate (ml/minute/1.73 m2) 70.3
Women
Median values for serum ALP (U/l) 170
Number at risk 465
Age (years) 56.4 ± 12.8
Systolic blood pressure (mmHg) 137
Diastolic blood pressure (mmHg) 80
Antihypertensive medication use (%) 26
Thyroid disease (%) 0.4
Body mass index (kg/m2) 22.6
Current drinker (%) 13.3
Current smoker (%) 3.6
Serum triglycerides (mg/dl) 113
Diabetes (%) 5.8
Serum aspartate aminotransferase (AST) (IU/l) 21.4
Serum γ-glutamyltranspeptidase (γ-GTP)IU/l) 20
Serum creatinine, (mg/dl) 0.724
Glomerular filtration rate (ml/minute/1.73 m2) 66.7
Age presented as mean ± standard deviation. Serum alkaline phosphatase (ALP) lev
men and <199 U/l, 199 to 240 U/l, 241 to 290 U/l, and >290 U/l for women.Table 2 presents the OR and 95% CIs for hypertension
according to ALP levels. While no significant association was
observed for men, it was significantly positive for women.
The multivariable adjusted OR and 95% CI for hypertension
per increment of 1-log ALP were 0.95 (95% CI: 0.56 to 1.59)
for men and 1.57 (95% CI: 1.07 to 2.33) for women.
We also investigated the sex-specific influence of
drinking status on ALP levels and found a significantlye phosphatase levels
ALP quartiles
Q2 Q3 Q4 (high) P value
209 250 318
215 207 208
63.2 ± 11.5 65.3 ± 10.2 65.7 ± 10.2
142 143 141 0.504
85 86 85 0.390
22 25 26 0.735
0.5 1.0 0.0 0.300
23.8 23.6 23.3 0.337
53 46 45 0.002
23 27 29 0.105
138 153 142 0.044
7 11 12 0.267
25 25 26 0.061
41 51 60 <0.001
0.93 0.92 0.91 0.562
68.4 68.5 70.7 0.411
220 263 337
458 467 456
63.7 ± 10.8 64.3 ± 9.6 65.8 ± 9.2
140 141 142 <0.001
83 84 84 <0.001
25 24 31 0.029
0.7 1.3 0.9 0.534
22.9 23.2 23.1 0.083
13.4 10.2 11.1 0.338
3.3 4.7 4.5 0.682
118 127 133 <0.001
5.4 5.6 7.1 0.689
21.9 22.0 23.1 0.011
24 25 31 <0.001
0.715 0.716 0.724 0.740
67.7 67.7 66.5 0.574
els for quartiles were <194 U/l, 194 to 228 U/l, 229 to 275 U/l, and >275 U/l for
Table 2 Sex-specific odds ratio and 95% confidence interval for hypertension in relation to alkaline phosphatase levels
ALP quartiles 1 SD increments
in ALP
Log ALP
Q1 (low) Q2 Q3 Q4 (high) P for trend
Men
Number at risk 205 215 207 208
Number of cases (%) 118 (58) 134 (62) 134 (65) 128 (62)
Age-adjusted OR 1.00 1.26 (0.85 to 1.88) 1.30 (0.87 to 1.95) 1.11 (0.75 to 1.66) 0.590 1.00 (0.87 to 1.16) 1.00 (0.62 to 1.59)
Multivariable OR 1.00 1.30 (0.86 to 1.99) 1.29 (0.84 to 1.99) 1.16 (0.75 to 1.79) 0.535 0.98 (0.83 to 1.15) 0.95 (0.56 to 1.59)
Women
Number at risk 465 458 467 456
Number of cases (%) 186 (40) 271 (59) 273 (58) 305 (67)
Age-adjusted OR 1.00 1.33 (0.98 to 1.78) 1.22 (0.91 to 1.64) 1.61 (1.19 to 2.17) 0.006 1.21 (1.09 to 1.35) 1.81 (1.26 to 2.60)
Multivariable OR 1.00 1.29 (0.95 to 1.76) 1.14 (0.84 to 1.55) 1.49 (1.09 to 2.04) 0.041 1.17 (1.04 to 1.31) 1.57 (1.07 to 2.33)
Multivariable odds ratio (OR) adjusted further for age, body mass index, smoking, alcohol intake, diabetes, thyroid disease, serum triglycerides, serum aspartate
aminotransferase (AST) , serum γ-glutamyltranspeptidase (γ-GTP) and glomerular filtration rate. Hypertension defined as systolic blood pressure ≥140mmHg and/
or diastolic blood pressure ≥90 mmHg and/or use of antihypertensive agents. Serum alkaline phosphatase (ALP) levels for quartiles were <194 U/l, 194 to 228 U/l,
229 to 275 U/l, and >275 U/l for men and <199 U/l, 199 to 240 U/l, 241 to 290 U/l, and >290 U/l for women.
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drinker, current light-to-moderate drinker (1 to 6 times/
week), and current heavy-drinker (every day)) for men, while
essentially the same tendency was observed for women but
without reaching statistical significance. For men, the age-
adjusted mean values of ALP were 254 for nondrinkers,
235 for current light-to-moderate drinkers, and 233 for
current heavy drinkers (P = 0.003), and for women the
corresponding values were 252, 247, and 240 (P = 0.292).
We also evaluated the risk of hypertension for drinkers.
Drinking status for men showed a significant association
with risk of hypertension but not so for women. The age-
adjusted OR and 95% CI of hypertension for drinking
status (nondrinker or current drinker) were 1.70 (95% CI:
1.28 to 2.27; P <0.001) for men and 1.15 (95% CI: 0.84 to
1.57; P = 0.385) for women.
Table 3 presents the ORs and 95% CIs for hypertension
by ALP level in relation to drinking status. Significantly
positive associations were observed for nondrinkers, but
not for drinkers. For nondrinkers the adjusted OR and
95% CI for hypertension per increment of 1-log ALP were
3.32 (95% CI: 1.38 to 8.02) for men and 1.68 (95% CI: 1.11
to 2.55) for women, and for drinkers the corresponding
values were 0.42 (95% CI: 0.20 to 0.89) for men and 1.03
(95% CI: 0.30 to 3.50) for women.
Another analysis was performed to evaluate associa-
tions between serum ALP levels and systolic and dia-
stolic blood pressure. We found that ALP levels were
independently positively associated with both systolic
and diastolic blood pressure for nondrinkers but not for
drinkers. The results of multiple (including antihyper-
tensive medication use) linear regression analysis of sys-
tolic and diastolic blood pressure per increment of 1-log
ALP for nondrinkers were regression coefficient β = 2.10
(95% CI: 1.08 to 4.09; P = 0.028) and β = 3.54 (95% CI:1.81 to 6.92; P <0.001) for men, and β = 1.62 (95% CI: 1.19
to 2.21; P = 0.002) and β = 2.02 (95% CI: 1.48 to 2.75;
P <0.001) for women, while for drinkers the correspond-
ing values were β = 0.96 (95% CI: 0.57 to 1.64; P = 0.884)
and β = 0.62 (95% CI: 0.37 to 1.06; P = 0.082) for men,
and β = 0.80 (95% CI: 0.34 to 1.91; P = 0.619) and β = 0.91
(95% CI: 0.38 to 2.16; P = 0.822) for women, respectively.
We also identified a significant effect on hypertension
of interaction between ALP levels and drinking status
(nondrinkers or current drinkers) for men but not for
women. The multivariable-adjusted P value of this effect
of interaction on hypertension was 0.002 for men and
0.900 for women.
Discussion
Our findings demonstrate that serum ALP is associated
with hypertension for both male and female nondrinkers,
but not for drinkers. For analyses of associations between
ALP and blood pressure, alcohol consumption should
thus be considered a potential confounder.
A previous study of 4,155 men and women conducted
by the United States National Health and Nutrition
Examination Survey reported that ALP showed a signifi-
cant association with higher frequency of hypertension
(P = 0.01). Moreover, compared with the lowest quartiles
of ALP, the adjusted OR associated with the highest
quartiles was 1.6 (95% CI: 1.0 to 2.5) [3]. Another study
of 79 South African men reported that 24-hour systolic
blood pressure was positively associated (regression co-
efficient β= 0.289, P = 0.018) with serum ALP [15].
Although no such significant association was observed
for men in our study, a significantly positive association
was observed for women. We found further that, when
these analyses were restricted to nondrinkers, the associ-
ation became significantly positive for men and remained
Table 3 Sex-specific data for hypertension in relation to alkaline phosphatase levels and drinking status




Q1 (low) Q2 Q3 Q4 (high) P for trend
Nondrinker men
Number at risk 77 100 112 115
Number of cases (%) 35 (45) 50 (50) 69 (62) 73 (63)
Age-adjusted OR 1.00 1.27 (0.69 to 2.34) 1.91 (1.04 to 3.48) 1.98 (1.09 to 3.62) 0.011 1.40 (1.10 to 1.79) 2.96 (1.33 to 6.58)
Multivariable OR 1.00 1.37 (0.71 to 2.64) 1.96 (1.03 to 3.73) 2.23 (1.16 to 4.28) 0.009 1.46 (1.12 to 1.91) 3.32 (1.38 to 8.02)
Nondrinker women
Number at risk 390 399 423 412
Number of cases (%) 162 (42) 238 (60) 250 (59) 277 (67)
Age-adjusted OR 1.00 1.34 (0.97 to 1.84) 1.27 (0.93 to 1.73) 1.64 (1.19 to 2.27) 0.006 1.22 (1.08 to 1.37) 1.84 (1.24 to 2.72)
Multivariable OR 1.00 1.33 (0.96 to 1.85) 1.21 (0.87 to 1.67) 1.58 (1.12 to 2.21) 0.023 1.19 (1.05 to 1.35) 1.68 (1.11 to 2.55)
Drinker men
Number at risk 128 115 95 93
Number of cases (%) 83 (65) 84 (73) 65 (68) 55 (59)
Age-adjusted OR 1.00 1.53 (0.88 to 2.67) 1.14 (0.64 to 2.02) 0.76 (0.44 to 1.33) 0.295 0.82 (0.67 to 1.00) 0.59 (0.31 to 1.14)
Multivariable OR 1.00 1.39 (0.78 to 2.50) 0.94 (0.51 to 1.73) 0.62 (0.34 to 1.14) 0.103 0.73 (0.58 to 0.91) 0.42 (0.20 to 0.89)
Drinker women
Number at risk 75 59 44 44
Number of cases (%) 24 (32) 33 (56) 23 (52) 28 (64)
Age-adjusted OR 1.00 1.17 (0.52 to 2.66) 0.87 (0.36 to 2.12) 1.34 (0.54 to 3.28) 0.711 1.16 (0.87 to 1.55) 1.60 (0.58 to 4.41)
Multivariable OR 1.00 0.89 (0.36 to 2.20) 0.70 (0.26 to 1.87) 1.14 (0.42 to 3.09) 0.953 1.01 (0.68 to 1.49) 1.03 (0.30 to 3.50)
Data presented as odds ratio (95% confidence interval). Multivariable odds ratio (OR) adjusted further for age, body mass index, smoking, alcohol intake, diabetes, thyroid disease, serum triglycerides, serum aspartate
aminotransferase (AST), serum γ-glutamyltranspeptidase (γ-GTP) and glomerular filtration rate. Hypertension defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or use of
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tive associations were observed for either male or female
drinkers.
Previous studies have reported that ALP levels are af-
fected by alcohol consumption [5,6]. A Danish general
population study reported that the amount of alcohol in-
take was inversely and significantly associated with ALP
levels for both men and women [5]. Our study also
showed that ALP levels were significantly associated
with drinking status for men, and that for women, even
though the association was not statistically significant,
essentially the same tendency was observed. Further, al-
cohol consumption is positively associated with risk of
hypertension [7]. NIPPON DATA 90 reported that a
large percentage of hypertensive subjects in a general
Japanese male population suffered from alcohol-induced
hypertension [14]. This is compatible with our study’s
findings that drinking status is a significant risk factor
for hypertension for men but not for women. The asso-
ciation between ALP levels and hypertension may this
be seriously confounded by alcohol consumption, espe-
cially for Japanese men. The significant effect on hyper-
tension of the interaction between ALP levels and
drinking status (nondrinker or current drinker) identi-
fied for men but not for women may be induced by such
drinking-related mechanisms.
The mechanisms for the positive association of higher
ALP levels with risk of hypertension have not yet been
elucidated. Tonelli and colleagues reported identifying
an independent relationship between higher levels of
ALP and overall mortality for survivors of myocardial in-
farction and in a general population sample. In their
study, systolic blood pressure was positively associated
with ALP levels [16]. Orita and colleagues found a posi-
tive correlation between serum total ALP activity and
bone-type ALP activity in mouse calcified vascular le-
sions [17]. Another study demonstrated the presence of
bone-type ALP in human vascular smooth muscle cells
[18], which suggests that a higher level of bone-type
ALP activity may accelerate the development of cardio-
vascular events through cardiovascular calcification,
which is also positively associated with hypertension.
Jensky and colleagues reported that among 9,510 partici-
pants (42.5% women) who underwent electron beam
computed tomography scanning as part of a routine
health maintenance scanning, systolic hypertension fea-
tures a robust and important significant correlation with
calcified atherosclerosis [19].
Another possible mechanism for the association be-
tween ALP levels and risk of hypertension is impaired
vascular homeostasis, since hematopoietic stem cells de-
rived from bone marrow play a major role in vascular
homeostasis [20-22]. Since osteoblasts, whose activity
can be assessed by bone-type ALP expression [1,23],regulate the production of hematopoietic stem cells in
bone marrow [24-26], serum ALP levels may correlate
with vascular homeostatic activity. Some previous studies
have reported that hematopoietic stem cells participate in
the pathogenesis of atherosclerosis [27] and promote
angiogenesis [20], while other studies established that vas-
cular maturation and stabilization were end stages of
neovascularization and angiogenesis [28]. Higher ALP
levels may thus indicate progression of atherosclerosis. Yet
another study showed that elevated ALP levels were asso-
ciated with atherosclerosis, which leads to peripheral arter-
ial disease and was assessed using the ankle-brachial blood
pressure index, and that this association was independent
of other traditional cardiovascular risk factors [29]. Fur-
thermore, hypertension is not only a well-established car-
diovascular risk factor but also increases the risk of
atherosclerosis [30]. Elevated ALP levels may therefore
constitute a risk for hypertension due to progressive ath-
erosclerosis. A previous study of ours, the Circulatory Risk
in Community Study, detected a significantly positive asso-
ciation between ALP levels and blood pressure (either sys-
tolic and/or diastolic) for both men and women, which
may induce these mechanisms [8]. On the other hand, the
nature of those mechanisms also indicated that elevated
ALP levels might perform an important role as direct sur-
rogate markers for progressive atherosclerosis and blood
pressure as an indirect surrogate marker for atheroscler-
osis. In this respect, previous studies, even after adjust-
ments for systolic blood pressure and antihypertensive
medication use, showed significant associations between
ALP level and mortality [16], and incidence of stroke [8].
The same mechanisms also point to the clinical rele-
vance of this study’s finding that among ALP can be
used for nondrinkers to evaluate risk of hypertension or
progression of atherosclerosis, which might be useful for
controlling blood pressure.
This study has certain potential limitations, which
warrant consideration. First, because no measurements
of the ALP isozyme were performed [31], we could not
assess which type of ALP was associated with the risk
of hypertension. Second, we did not have access to
menopausal status data, which may have affected ALP
levels [32], but a significantly positive association was
observed between ALP levels and risk of hypertension
for nondrinking women. Further investigations using
menopausal data are therefore necessary. Third, only
limited data for thyroid disease were available, which
may have confounded the associations between ALP and
risk of hypertension [33]. Nevertheless, we found a sig-
nificant association for both nondrinking men and
women, even though the prevalence of thyroid disorder
in the general Japanese population reportedly shows a
strong sex difference [34]. Fourth, even though a previ-
ous Japanese study reported that, compared with never-
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cantly higher risk of cardiovascular disease but their fe-
male counterparts did not [10], we could not conduct an
analysis of never-drinkers because data for this group
were not available. However, we found a significantly
positive association between ALP levels and hyperten-
sion for both nondrinking men and women. Although
the association between ALP levels and risk of hyper-
tension was shown to be independent of the traditional
risk factors, we did not adjusted for other potential
confounders whose values were associated with ALP,
such as calorie, protein, vitamin C, magnesium, and
zinc deficiencies [35], and drinking volume of alcohol
consumption.
In conclusion, serum ALP is associated with hyperten-
sion for both male and female nondrinkers, but not for
drinkers. For analyses of associations between ALP and
blood pressure, alcohol consumption should thus be
considered a potential confounder.
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